Latest Insider Transactions at Savara Inc (SVRA)
This section provides a real-time view of insider transactions for Savara Inc (SVRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Savara Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Savara Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
60,200
+4.93%
|
$60,200
$1.08 P/Share
|
|
Sep 30
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
50,000
+4.34%
|
$50,000
$1.3 P/Share
|
|
Sep 29
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
47,500
+4.32%
|
$47,500
$1.28 P/Share
|
|
Sep 28
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
39,552
+3.79%
|
$39,552
$1.28 P/Share
|
|
Aug 18
2021
|
Nevan C Elam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,288
+7.84%
|
$0
$0.52 P/Share
|
|
Aug 18
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
30,736
+1.58%
|
$30,736
$1.2 P/Share
|
|
Aug 18
2021
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
11,900
+3.33%
|
$11,900
$1.19 P/Share
|
|
Aug 17
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
66,554
+6.66%
|
$66,554
$1.18 P/Share
|
|
Aug 17
2021
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
15,000
+4.31%
|
$15,000
$1.18 P/Share
|
|
May 21
2021
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+3.05%
|
$10,000
$1.63 P/Share
|
|
May 19
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
5,003
+0.57%
|
$5,003
$1.58 P/Share
|
|
May 18
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
50,000
+5.48%
|
$50,000
$1.62 P/Share
|
|
May 17
2021
|
Badrul A. Chowdhury CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
50,000
-25.0%
|
$50,000
$1.56 P/Share
|
|
May 15
2021
|
Badrul A. Chowdhury CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+50.0%
|
-
|
|
Apr 19
2021
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
27,400
+8.17%
|
$27,400
$1.82 P/Share
|
|
Mar 22
2021
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
24,100
+7.91%
|
$48,200
$2.07 P/Share
|
|
Mar 15
2021
|
David A Ramsay |
BUY
Open market or private purchase
|
Direct |
689,655
+45.93%
|
$689,655
$1.45 P/Share
|
|
Mar 15
2021
|
Joseph S Mc Cracken |
BUY
Open market or private purchase
|
Direct |
68,965
+29.06%
|
$68,965
$1.45 P/Share
|
|
Mar 15
2021
|
David L Lowrance CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
13,793
+50.0%
|
$13,793
$1.45 P/Share
|
|
Feb 22
2021
|
Matthew Pauls CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
28,700
+10.06%
|
$28,700
$1.74 P/Share
|
|
Dec 15
2020
|
Nevan C Elam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,930
+10.64%
|
$0
$0.52 P/Share
|